Company: IPCX
Filing Date: 2025-04-29
Form Type: 8-K
Source: 0001213900-25-036378
Chunk: 4

Company: Inflection Point Acquisition Corp. III
Filing Date: 2025-04-29
Form: 8-K
Item: Item 3.02
Chunk 4
---
.

Item 5.02. Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On
April 24, 2025, in connection with the IPO, Daniel J. Hoffman, Dr. Kamal Ghaffarian, William Denkin, and Noah G. Levy were appointed to
the board of directors of the Company (the “ Board”). Mr. Hoffman, Dr. Ghaffarian, Mr. Denkin and Mr. Levy are independent
directors. Effective April 24, 2025, Mr. Hoffman, Mr. Levy and Mr. Denkin were appointed to the Board’s Audit Committee and Compensation
Committee, with Mr. Hoffman serving as chair of the Audit Committee and Mr. Denkin serving as chair of the Compensation Committee.

Following
the appointment of Mr. Hoffman, Dr. Ghaffarian, Mr. Denkin and Mr. Levy, the Board is comprised of three classes. The term of office of
the first class of directors, Class I, consisting of Mr. Denkin, will expire at the Company’s first annual meeting of shareholders.
The term of office of the second class of directors, Class II, consisting of Dr. Ghaffarian and Mr. Hoffman, will expire at the Company’s
second annual meeting of shareholders. The term of office of the third class of directors, Class III, consisting of Michael Blitzer
(Chairman of the Board) and Mr. Levy, will expire at the Company’s third annual meeting of shareholders.

On
April 24, 2025, in connection with their appointments to the Board, each of the members of the Board entered into the Letter Agreement
as well as an indemnity agreement with the Company in the form previously filed as Exhibit 10.6 to the Registration Statement.

Other
than the foregoing, none of the directors are party to any arrangement or understanding with any person pursuant to which they were appointed
as directors, nor are they party to any transactions required to be disclosed under Item 404(a) of Regulation S-K involving
the Company.

The
foregoing descriptions of the Letter Agreement and the form of indemnity agreement do not purport to be complete and are qualified in
their entireties by reference to the Letter Agreement and form of indemnity agreement, copies of which are attached as Exhibit 10.1 and
10.6 hereto, respectively, and are incorporated herein by reference.

Item 5.03